谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Primary prophylaxis with G-CSF may improve outcomes in patients with newly diagnosed stage III/IV Hodgkin lymphoma treated with brentuximab vedotin plus chemotherapy.

David Straus,Graham Collins,Jan Walewski,Pier Luigi Zinzani,Andrew Grigg,Anna Sureda,Arpad Illes,Tae Min Kim,Sergey Alekseev,Lena Specht,Valeria Buccheri,Anas Younes,Joseph Connors,Andres Forero-Torres,Keenan Fenton,Ashish Gautam,Indra Purevjal,Rachael Liu,Andrea Gallamini

LEUKEMIA & LYMPHOMA（2020）

引用 10|浏览85
暂无评分
关键词
Hodgkin lymphoma, brentuximab vedotin, frontline therapy, growth factor, primary prophylaxis
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要